Streamlining breast cancer and colorectal cancer biosimilar regulations to improve treatment access in Latin America: an expert panel perspective.
Lancet Oncol
; 23(7): e348-e358, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35772466
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Colorectal Neoplasms
/
Biosimilar Pharmaceuticals
Type of study:
Guideline
Limits:
Female
/
Humans
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Country of publication:
United kingdom